FDA approves Dornier's thermotherapy device:
This article was originally published in Clinica
The FDA has approved Dornier MedTech's microwave thermotherapy device to treat benign prostatic hyperplasia. According to the Georgia-based company, the portable and compact Urowave unit delivers 90 watts of power to the tissue, which was "more than any other product on the market". The device, which also offers fully-automated software, has a urethral therapy probe which allows 360-degree cooling.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.